Top View
- Disabling and Potentially Permanent Side Effects Lead to Suspension Or Restrictions of Quinolone and Fluoroquinolone Antibiotics
- Effects of Magnesium, Calcium, and Aluminum Chelation on Fluoroquinolone Absorption Rate and Bioavailability: a Computational Study
- (12) Patent Application Publication (10) Pub. No.: US 2009/0324736A1 Johnson Et Al
- Ubiquitous Nature of Fluoroquinolones: the Oscillation Between Antibacterial and Anticancer Activities
- Critically Important Antimicrobials for Human Medicine – 5Th Revision. Geneva
- 6-Veterinary-Medicinal-Products-Criteria-Designation-Antimicrobials-Be-Reserved-Treatment
- Pharmacokinetics and Pharmacodynamics of Fluoroquinolones
- WO 2010/083148 Al
- 2 1 V16 4 A2
- Antibiotic Prophylaxis to Prevent Spontaneous Bacterial Peritonitis in People with Liver Cirrhosis: a Network Meta-Analysis (Review)
- EMA to Review Persistenceofside Effects Known to Occur With
- Fighting Bacterial Resistance: Approaches, Challenges, and Opportunities in the Search for New Antibiotics
- ANTIMICROBIAL AGENTS and CHEMOTHERAPY VOLUME 37 0 DECEMBER 1993 * NUMBER 12 Robert C
- EASL Clinical Practice Guidelines for the Management of Patients with Decompensated Cirrhosisq
- Original Article Apoptosis of Human Hepatocellular Carcinoma Cells SMMC-7721 Induced by C-3 Methylidene Thiazolidinedione Acetic Acid
- Handbook of Anti-Tuberculosis Agents
- BSAC Standardized Disc Susceptibility Testing Method
- Management and Treatment of Patients with Cirrhosis and Portal Hypertension: Recommendations from The
- Methicillin-Resistant S. Aureus (MRSA)
- A Novel Predictive Model for the Anti-Bacterial, Anti-Malarial and Herg Cardiac QT Prolongation Properties of Fluoroquinolones Clifford Fong
- Dissecting Mechanisms of Antimalarials Using CRISPR/Cas9 Editing in Plasmodium Falciparum
- Face-To-Face Anthrax Prophylaxis Screening Tool
- Administration of a Bowel Cleanser and an Antibiotic for the Treatment of Bowel Disease
- Quinolones and Fluoroquinolones Art. 31
- From Chloroquine to Antineoplastic Drugs? the Story of Antibacterial Quinolones
- Gatifloxacin, Moxifloxacin, and Balofloxacin Resistance Due To
- PRAC Recommendations on Signals Adopted at the PRAC Meeting of 26-29 September 2016
- WHO List of Critically Important Anti-‐Microbials, 2011 Rev 3
- A Risk-Benefit Assessment of Levofloxacin in Respiratory, Skin and Skin Structure, and Urinary Tract Infections
- Environmentally Friendly Fluoroquinolone Derivatives with Lower Plasma Protein Binding Rate Designed Using 3D-QSAR, Molecular Do
- Fluoroquinolones, Risk of Heart Valve Regurgitation,DHPC
- Lack of Influence of Substrate on Ligand Interaction with the Human Multidrug and Toxin Extruder, MATE1 S
- Studies on Mutational Resistance to Nalidixic Acid in Escherichia Coli
- Urologic Surgery Antimicrobial Prophylaxis Best Practice
- Moxifloxacin Safety and Position in Today's Microbiological Environement